Health insurer Cigna Corp. will get extra price discounts from
drug makers if new cholesterol medications don’t help patients as much as
expected, a significant step in a broader push to tie the cost of drugs
to how well they work.
Such "value-based" deals are becoming more common as rising costs spur customers to demand assurances they are getting what they pay for.
To read more on this story, be sure to check the Wall Street Journal published article, "Health Insurers Push to Tie Drug Prices to Outcomes".
HORIZON Health Ventures is a healthcare cost management solutions company used by insurance
brokers, employee benefit consultants, third-party administrators,
insurance companies, and associations, to bring proven thought
leadership and strategy to the management of their clients healthcare
costs. To learn more about HHV and their services, please visit http://horizonhealthventures.com/
No comments:
Post a Comment